Войны мозга. Научные споры вокруг разума и сознания. Марио Борегар

Keeps Us Healthy (New York: Simon & Schuster, 1987).

      36

      D. Evans, Placebo: The Belief Effect (London: HarperCollins, 2004).

      37

      D. E. Moerman, “Cultural Variations in the Placebo Effect: Ulcers, Anxiety and Blood Pressure,” Medical Anthropology Quarterly 14 (2000): 51–72.

      38

      A. J. de Crean et al., “Effect of Colour of Drugs: Systemic Review of Perceived Effect of Drugs and of Their Effectiveness,” British Medical Journal 313 (1996): 1624-26.

      39

      I. Hashish et al., “Reduction of Postoperative Pain and Swelling by Ultrasound Treatment: A Placebo Effect,” Pain 33 (1988): 303-11.

      40

      J. D. Levine, N. C. Gordon, and H. L. Fields, “The Mechanism of Placebo Analgesia,” Lancet 312 (1978): 654-57.

      41

      J. K. Zubieta et al., “Placebo Effects Mediated by Endogenous Opioid Neurotransmission and i-opioid Receptors,” Journal of Neuroscience 25 (2005), 7754-62.

      42

      R. de la Fuente-Fernandez et al., “Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson’s Disease,” Science 293 (2001): 1164-66.

      43

      A. J. de Craen et al., “Placebo Effect in the Treatment of Duodenal Ulcer,” British Journal of Clinical Pharmacology 48 (1999): 853-60.

      44

      K. Schapira et al., “Study on the Effect of Tablet Colour in the Treatment of Anxiety States,” British Medical Journal 2 (1970): 446-49.

      45

      I. Kirsch and G. Sapirstein, “Listening to Prozac but Hearing Placebo: A Meta-analysis of Antidepressant Medication,” Prevention & Treatment 1 (1998): 2a. Документ на сайте: http://journals.apa.org/prevention.

      46

      L. A. Cobb et al., “An Evaluation of Internal-Mammary-Artery Ligation by a Double-Blind Technique,” New England Journal of Medicine 260 (1959): 1115-18.

      47

      J. B. Moseley Jr. et al., “Arthroscopic Treatment of Osteoarthritis of the Knee: A Perspective, Randomized, Placebo-Controlled Trial: Results of a Pilot Study,” American Journal of Sports Medicine 24 (1996): 28–34.

      48

      J. B. Moseley et al., “A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee,” New England Journal of Medicine 347 (2002): 81–88.

      49

      C. McRae et al., “Effects of Perceived Treatment on Quality of Life and Medical Outcomes in a Double-Blind Placebo Surgery Trial,” Archives of General Psychiatry 61 (2004): 412-20.

      50

      McRae et al., “Effects of Perceived Treatment on Quality of Life,” 418-19.

      51

      E. D. Eaker, J. Pinsky, and W. P. Castelli, “Myocardial Infarction and Coronary Death Among Women: Psychosocial Predictors from Twenty-Year Follow-Up of Women in the Framingham Study,” American Journal of Epidemiology 135 (1992): 854-64.

      52

      W. P. Kennedy, “The Nocebo Reaction,” Medical World 95 (1961): 203-5.

      53

      R. R. Reeves et al., “Nocebo Effects with Antidepressant Clinical Drug Trial Placebos,” General Hospital Psychiatry 29 (2007): 275-77.

      54

      Reeves et al., “Nocebo Effects.”

      55

      A. J. Barsky and J. F. Borus, “Functional Somatic Syndromes,” Annals of Internal Medicine 130 (1999): 910-21.

      56

      M. G. Myers, J. A. Cairns, and J. Singer, “The Consent Form as a Possible Cause of Side Effects,” Clinical Pharmacology and Therapeutic 42 (1987): 250-53.

      57

      M. Flaten and T. D. Blumenthal, “Caffeine-Associated Stimuli Elicit Conditioned Response: An Experimental Model of the Placebo Effect,” Psychopharmacology 145 (1999): 105-12.

      58

      M. Shepherd, “The Placebo: From Specificity to the Non-Specific and Back,” Psychological Medicine 23 (1993): 569-78.

      59

      R. A. Preston et al., “Placebo-Associated Blood Pressure Response and Adverse Effects in the Treatment of Hypertension,” Archives of Internal Medicine 160 (2000): 1449-54.

      60

      J. A. Turner et al., “The Importance of Placebo Effects in Pain Treatment and Research,” Journal of the American Medical Association 271 (1994): 1609-14.

      61

      P. Enck, F. Benedetti, and M. Schedlowski, “New Insights into the Placebo and Nocebo Responses,” Neuron 59 (2008): 195–206.

      62

      T. Koyama et al., “The Subjective Experience of Pain: Where Expectations Become Reality,” Proceedings of the National Academy of Sciences of the United States of America 102 (2005): 12950-55.

      63

      H. Benson, “The Nocebo Effect: History and Physiology,” Preventive Medicine 26 (1997): 612-15.

      64

      C. K. Meador, “Hex Death: Voodoo Magic or Persuasion?” Southern Medical Journal 85 (1992): 244-47.

      65

      H. Basedow, The Australian Aborigenal (Adelaide, Australia: Preece, 1925). Цитируется по изданию: W. B. Cannon, “Voodoo Death,” American Anthropology 44 (1942): 169-81.

      66

      Meador, “Hex Death.”

      67

      H. Pilcher, “The Science of Voodoo: When Mind Attacks Body,” New Scientist, May 13, 2009. http://www.newscientist.com/article/mg20227081.100-the-science-of-voodoo-when-mind-attacks-body.html.

      68

      Meador, “Hex Death.”

      69

      S. Silberman, “Placebos Are Getting More Effective. Drugmakers Are Desperate to Know Why,” Wired Magazine, September 17, 2009. http://www.wired.com/medtech/drugs/magazine/1709/ff_placebo_effect?currentPage=all.

      70

      Silberman, “Placebos Are Getting More Effective.”

      71

      Silberman, “Placebos Are Getting More Effective.”

      72

      Silberman,